Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Current Treatment Options in Oncology|February 20, 2009
Cisplatin versus carboplatin in NSCLC: is there one "best" answer?Rachel E SanbornClinical Advances in Hematology & Oncology : H&O|September 17, 2005
Gastrointestinal stromal tumors and the evolution of targeted therapyRachel E Sanborn, Charles D BlankeExpert Opinion on Drug Safety|March 1, 2006
The safety of bevacizumabRachel E Sanborn, Alan B SandlerExpert Review of Clinical Pharmacology|January 16, 2014
Erlotinib: applications in therapy and current status of researchRachel E Sanborn, Angela M DaviesDermatologic Clinics|November 21, 2007
Cutaneous reactions to chemotherapy: commonly seen, less described, little understoodRachel E Sanborn, David A SauerThoracic Surgery Clinics|December 18, 2008
Adjuvant therapy for non-small cell lung cancer with mediastinal nodal involvementRachel E Sanborn, Brian E LallyCancer Treatment Reviews|April 16, 2026
Integrin beta-6: Its emerging role as a therapeutic target in solid tumorsRachel E Sanborn, Solange Peters, David BarbieThoracic Surgery Clinics|December 18, 2008
Definitive chemoradiotherapy for non-small cell lung cancer with N2 diseaseShilpen Patel, Rachel E Sanborn, Charles R ThomasThoracic Surgery Clinics|December 18, 2008
Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvementBrandon H Tieu, Rachel E Sanborn, Charles R ThomasAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Beyond Checkpoint Inhibitors: Enhancing Antitumor Immune Response in Lung CancerRachel E Sanborn, Famke L Schneiders, Suresh Senan, et al.Pageof 7